The predictive value of energy spectral CT parameters for assessing Ki-67 expression of lung cancer

能量谱CT参数对评估肺癌Ki-67表达的预测价值

阅读:1

Abstract

BACKGROUND: To investigate the predictive value of energy spectral CT parameters for Ki-67 expression in lung cancer. METHODS: In this retrospective analysis, 27 primary lung cancer patients confirmed by pathological examination were enrolled between December 2018 and February 2019. All patients underwent baseline arterial phase (AP) and venous phase (VP) energy spectral CT scanning followed by surgery in our institution. The iodine concentration (IC), normalized iodine concentration (NIC) and the slope of 40-80 keV energy spectrum curve (λ(HU)) were derived from dual-energy virtual imaging on a Siemens postprocessed workstation. Immunohistochemical examination was performed to analyze Ki-67 expression. The ROC curves were used for predicting the performance of energy spectral parameters for Ki-67 expression. RESULTS: The tumors appeared larger in Ki-67 high expression group than the low expression group (P=0.046). The energy spectral parameters were higher in venous phase when compared to arterial phase, but only the venous phase NIC (vpNIC) was significantly different from that of the arterial phase NIC (apNIC) (P<0.01). There are significant differences in high and low Ki-67 expression groups for vpNIC and venous λ(HU) (vpλ(HU)), (P=0.033 and 0.037 for vpNIC and vpλ(HU), respectively). vpNIC ROC analysis showed borderline P value (P=0.056) with an AUC, sensitivity (SE), specificity (SP) and cut-off value (0.717, 92.86, 61.54 and ≤0.347), respectively. The AUC, SE, SP and cut-off value of vpλ(HU) were 0.698, 92.86, 53.85 and ≤2.407, respectively. CONCLUSIONS: The energy spectral parameters (NIC and λ(HU)) of venous phase might be used for predicting Ki-67 stratification. The venous phase energy spectral parameters were higher than the arterial phase. Furthermore, low expression Ki-67 group showed association with higher IC, NIC and λ(HU) than high expression group.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。